Recent Advances and Therapeutic Implications of 2-Oxoglutarate-Dependent Dioxygenases in Ischemic Stroke.

Collaborators GBDS (2021) Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol 20(10):795–820

doi: 10.1016/S1474-4422(21)00252-0

Zhang R, Liu H, Pu L, Zhao T, Zhang S, Han K et al (2023) Global burden of ischemic stroke in young adults in 204 countries and territories. Neurology 100(4):e422–e434

pubmed: 36307222 doi: 10.1212/WNL.0000000000201467

Rost NS, Brodtmann A, Pase MP, van Veluw SJ, Biffi A, Duering M et al (2022) Post-stroke cognitive impairment and dementia. Circ Res 130(8):1252–1271

pubmed: 35420911 doi: 10.1161/CIRCRESAHA.122.319951

Das J, Rajanikant GK (2018) Post stroke depression: the sequelae of cerebral stroke. Neurosci Biobehav Rev 90:104–14

pubmed: 29656030 doi: 10.1016/j.neubiorev.2018.04.005

Brorson JR, Cifu AS (2019) Management of patients with acute ischemic stroke. JAMA 322(8):777–778

pubmed: 31318383 doi: 10.1001/jama.2019.10436

Prabhakaran S, Ruff I, Bernstein RA (2015) Acute stroke intervention: a systematic review. JAMA 313(14):1451–1462

pubmed: 25871671 doi: 10.1001/jama.2015.3058

Deng G, Xiao J, Yu H, Chen M, Shang K, Qin C et al (2022) Predictors of futile recanalization after endovascular treatment in acute ischemic stroke: a meta-analysis. J Neurointerv Surg 14(9):881–885

pubmed: 34544824 doi: 10.1136/neurintsurg-2021-017963

O’Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW (2006) 1,026 experimental treatments in acute stroke. Ann Neurol 59(3):467–477

pubmed: 16453316 doi: 10.1002/ana.20741

Grossman AW, Broderick JP (2013) Advances and challenges in treatment and prevention of ischemic stroke. Ann Neurol 74(3):363–372

pubmed: 23929628 doi: 10.1002/ana.23993

Zhou Z, Lu J, Liu WW, Manaenko A, Hou X, Mei Q et al (2018) Advances in stroke pharmacology. Pharmacol Ther 191:23–42

pubmed: 29807056 doi: 10.1016/j.pharmthera.2018.05.012

Xu J, Wang A, Meng X, Yalkun G, Xu A, Gao Z et al (2021) Edaravone dexborneol versus edaravone alone for the treatment of acute ischemic stroke: a phase III, randomized, double-blind, comparative trial. Stroke 52(3):772–780

pubmed: 33588596 doi: 10.1161/STROKEAHA.120.031197

Cui LY, Zhu YC, Gao S, Wang JM, Peng B, Ni J et al (2013) Ninety-day administration of dl-3-n-butylphthalide for acute ischemic stroke: a randomized, double-blind trial. Chin Med J 126(18):3405–3410 (Engl)

pubmed: 24034079

Chen SQ, Mao DY, Wei DC, He WZ (2020) Human urinary kallindinogenase therapy for acute ischemic stroke according to Chinese ischemic stroke subclassification: Clinical efficacy and risk factors. Brain Behav 10(1):e01461

pubmed: 31793238 doi: 10.1002/brb3.1461

Wu D, Li M, Fisher M, Ji X (2022) Brain cytoprotection of ischemic stroke in the era of effective reperfusion. Sci Bull 67(23):2372–2375 (Beijing)

doi: 10.1016/j.scib.2022.11.019

Wu QJ, Tymianski M (2018) Targeting NMDA receptors in stroke: new hope in neuroprotection. Mol Brain 11(1):15

pubmed: 29534733 pmcid: 5851248 doi: 10.1186/s13041-018-0357-8

Giorgi C, Baldassari F, Bononi A, Bonora M, De Marchi E, Marchi S et al (2012) Mitochondrial Ca(2+) and apoptosis. Cell Calcium 52(1):36–43

pubmed: 22480931 pmcid: 3396846 doi: 10.1016/j.ceca.2012.02.008

Woodruff TM, Thundyil J, Tang SC, Sobey CG, Taylor SM, Arumugam TV (2011) Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener 6(1):11

pubmed: 21266064 pmcid: 3037909 doi: 10.1186/1750-1326-6-11

Ajoolabady A, Wang S, Kroemer G, Penninger JM, Uversky VN, Pratico D et al (2021) Targeting autophagy in ischemic stroke: from molecular mechanisms to clinical therapeutics. Pharmacol Ther 225:107848

pubmed: 33823204 pmcid: 8263472 doi: 10.1016/j.pharmthera.2021.107848

Jiang X, Andjelkovic AV, Zhu L, Yang T, Bennett MVL, Chen J et al (2018) Blood-brain barrier dysfunction and recovery after ischemic stroke. Prog Neurobiol 163–164:144–171

pubmed: 28987927 doi: 10.1016/j.pneurobio.2017.10.001

Zhang SR, Phan TG, Sobey CG (2021) Targeting the immune system for ischemic stroke. Trends Pharmacol Sci 42(2):96–105

pubmed: 33341247 doi: 10.1016/j.tips.2020.11.010

Hill MD, Goyal M, Menon BK, Nogueira RG, McTaggart RA, Demchuk AM et al (2020) Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. Lancet 395(10227):878–887

pubmed: 32087818 doi: 10.1016/S0140-6736(20)30258-0

Huo Y, Feng X, Niu M, Wang L, Xie Y, Wang L et al (2021) Therapeutic time windows of compounds against NMDA receptors signaling pathways for ischemic stroke. J Neurosci Res 99(12):3204–3221

pubmed: 34676594 doi: 10.1002/jnr.24937

Lapchak PA (2010) A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? Expert Opin Pharmacother 11(10):1753–1763

pubmed: 20491547 pmcid: 2891515 doi: 10.1517/14656566.2010.493558

Almeida JR, Souza GR, Silva JC, Saraiva SR, Junior RG, de Souza Siqueira Quintans J et al (2013) Borneol, a bicyclic monoterpene alcohol, reduces nociceptive behavior and inflammatory response in mice. Sci World J 2013:808460

Wu HY, Tang Y, Gao LY, Sun WX, Hua Y, Yang SB et al (2014) The synergetic effect of edaravone and borneol in the rat model of ischemic stroke. Eur J Pharmacol 740:522–531

pubmed: 24975100 doi: 10.1016/j.ejphar.2014.06.035

Yin W, Lan L, Huang Z, Ji J, Fang J, Wang X et al (2016) Discovery of a ring-opened derivative of 3-n-butylphthalide bearing NO/H2S-donating moieties as a potential anti-ischemic stroke agent. Eur J Med Chem 115:369–380

pubmed: 27031213 doi: 10.1016/j.ejmech.2016.03.044

Wang H, Ye K, Li D, Liu Y, Wang D (2022) DL-3-n-butylphthalide for acute ischemic stroke: an updated systematic review and meta-analysis of randomized controlled trials. Front Pharmacol 13:963118

pubmed: 36120291 pmcid: 9479342 doi: 10.3389/fphar.2022.963118

Shin S, Lee Y, Chang WH, Sohn MK, Lee J, Kim DY et al (2022) Multifaceted assessment of functional outcomes in survivors of first-time stroke. JAMA Netw Open 5(9):e2233094

pubmed: 36149652 pmcid: 9508656 doi: 10.1001/jamanetworkopen.2022.33094

Vink JJT, van Lieshout ECC, Otte WM, van Eijk RPA, Kouwenhoven M, Neggers SFW et al (2023) Continuous theta-burst stimulation of the contralesional primary motor cortex for promotion of upper limb recovery after stroke: a randomized controlled trial. Stroke 54(8):1962–1971

pubmed: 37345546 pmcid: 10358447 doi: 10.1161/STROKEAHA.123.042924

Dawson J, Pierce D, Dixit A, Kimberley TJ, Robertson M, Tarver B et al (2016) Safety, feasibility, and efficacy of vagus nerve stimulation paired with upper-limb rehabilitation after ischemic stroke. Stroke 47(1):143–150

pubmed: 26645257 doi: 10.1161/STROKEAHA.115.010477

Bahr-Hosseini M, Nael K, Unal G, Iacoboni M, Liebeskind DS, Bikson M et al (2023) High-definition cathodal direct current stimulation for treatment of acute ischemic stroke: a randomized clinical trial. JAMA Netw Open 6(6):e2319231

pubmed: 37342040 pmcid: 10285579 doi: 10.1001/jamanetworkopen.2023.19231

Barker RA, Gotz M, Parmar M (2018) New approaches for brain repair-from rescue to reprogramming. Nature 557(7705):329–334

pubmed: 29769670 doi: 10.1038/s41586-018-0087-1

Andrzejewska A, Dabrowska S, Lukomska B, Janowski M (2021) Mesenchymal stem cells for neurological disorders. Adv Sci 8(7):2002944 (Weinh)

doi: 10.1002/advs.202002944

Salminen A, Kauppinen A, Kaarniranta K (2015) 2-Oxoglutarate-dependent dioxygenases are sensors of energy metabolism, oxygen availability, and iron homeostasis: potential role in the regulation of aging process. Cell Mol Life Sci 72(20):3897–3914

pubmed: 26118662 doi: 10.1007/s00018-015-1978-z

Provenzano R, Besarab A, Wright S, Dua S, Zeig S, Nguyen P et al (2016) Roxadustat (FG-4592) Versus epoetin alfa for anemia in patients receiving maintenance hemodialysis: a phase 2, randomized, 6- to 19-week, open-label, active-comparator, dose-ranging, safety and exploratory efficacy study. Am J Kidney Dis 67(6):912–924

pubmed: 26846333 doi: 10.1053/j.ajkd.2015.12.020

Chen N, Hao C, Liu BC, Lin H, Wang C, Xing C et al (2019) Roxadustat treatment for anemia in patients undergoing long-term dialysis. N Engl J Med 381(11):1011–1022

pubmed: 31340116 doi: 10.1056/NEJMoa1901713

Chu HX, Jones NM (2016) Changes in hypoxia-inducible factor-1 (HIF-1) and regulatory prolyl hydroxylase (PHD) enzymes following hypoxic-ischemic injury in the neonatal rat. Neurochem Res 41(3):515–522

pubmed: 26108712 doi: 10.1007/s11064-015-1641-y

Barks A, Beeson MM, Hallstrom TC, Georgieff MK, Tran PV (2022) Developmental iron deficiency dysregulates TET activity and DNA hydroxymethylation in the rat hippocampus and cerebellum. Dev Neurosci 44(2):80–90

pubmed: 35016180 doi: 10.1159/000521704

Losman JA, Koivunen P, Kaelin WG Jr (2020) 2-Oxoglutarate-dependent dioxygenases in cancer. Nat Rev Cancer 20(12):710–726

pubmed: 33087883 doi: 10.1038/s41568-020-00303-3

Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A et al (2015) Proteomics. Tissue-based map of the human proteome. Science 347(6220):1260419

pubmed: 25613900 doi: 10.1126/science.1260419

Karuppagounder SS, Ratan RR (2012) Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics? J Cereb Blood Flow Metab 32(7):1347–1361

pubmed: 22415525 pmcid: 3390817 doi: 10.1038/jcbfm.2012.28

Watts ER, Walmsley SR (2019) Inflammation and hypoxia: HIF and PHD isoform selectivity. Trends Mol Med 25(1):33–46

pubmed: 30442494 doi: 10.1016/j.molmed.2018.10.006

Lee KE, Simon MC (2015) SnapShot: hypoxia-inducible factors. Cell 163(5):1288-e1

pubmed: 26590427 doi: 10.1016/j.cell.2015.11.011

Nandal A, Ruiz JC, Subramanian P, Ghimire-Rijal S, Sinnamon RA, Stemmler TL et al (2011) Activation of the HIF prolyl hydroxylase by the iron chaperones PCBP1 and PCBP2. Cell Metab 14(5):647–57

pubmed: 22055506 pmcid: 3361910 doi: 10.1016/j.cmet.2011.08.015

Ju S, Lim L, Wi K, Park C, Ki YJ, Choi DH et al (2021) LRP5 Regulates HIF-1alpha stability via interaction with PHD2 in ischemic myocardium. Int J Mol Sci 22(12):6581

Feng T, Zhao X, Gu P, Yang W, Wang C, Guo Q et al (2022) Adipocyte-derived lactate is a signalling metabolite that potentiates adipose macrophage inflammation via targeting PHD2. Nat Commun 13(1):5208

pubmed: 36064857 pmcid: 9445001 doi: 10.1038/s41467-022-32871-3

Metzen E, Berchner-Pfannschmidt U, Stengel P, Marxsen JH, Stolze I, Klinger M et al (2003) Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing. J Cell Sci 116(Pt 7):1319–26

pubmed: 12615973 doi: 10.1242/jcs.00318

Willam C, Maxwell PH, Nichols L, Lygate C, Tian YM, Bernhardt W et al (2006) HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation. J Mol Cell Cardiol 41(1):68–77

pubmed: 16765982 doi: 10.1016/j.yjmcc.2006.04.009

Tian YM, Mole DR, Ratcliffe PJ, Gleadle JM (2006) Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation. Biochem J 397(1):179–86

pubmed: 16509823 pmcid: 1479752 doi: 10.1042/BJ20051996

Stiehl DP, Wirthner R, Koditz J, Spielmann P, Camenisch G, Wenger RH (2006) Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. J Biol Chem 281(33):23482–91

pubmed: 16790428 doi: 10.1074/jbc.M601719200

Seth P, Krop I, Porter D, Polyak K (2002) Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression). Oncogene 21(5):836–43

pubmed: 11850811 doi: 10.1038/sj.onc.1205113

Appelhoff RJ, Tian YM, Raval RR, Turley H, Harris AL, Pugh CW et al (2004) Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 279(37):38458–65

pubmed: 15247232 doi: 10.1074/jbc.M406026200

Babosova O, Kapralova K, Raskova Kafkova L, Korinek V, Divoky V, Prchal JT et al (2019) Iron chelation and 2-oxoglutarate-dependent dioxygenase inhibition suppress mantle cell lymphoma’s cyclin D1. J Cell Mol Med 23(11):7785–95

pubmed: 31517438 pmcid: 6815829 doi: 10.1111/jcmm.14655

Mikhaylova O, Ignacak ML, Barankiewicz TJ, Harbaugh SV, Yi Y, Maxwell PH et al (2008) The von Hippel-Lindau tumor suppressor protein and Egl-9-Type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress. Mol Cell Biol 28(8):2701–17

pubmed: 18285459 pmcid: 2293119 doi: 10.1128/MCB.01231-07

Cummins EP, Berra E, Comerford KM, Ginouves A, Fitzgerald KT, Seeballuck F et al (2006) Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci U S A 103(48):18154–9

pubmed: 17114296 pmcid: 1643842 doi: 10.1073/pnas.0602235103

Siddiq A, Aminova LR, Troy CM, Suh K, Messer Z, Semenza GL et al (2009) Selective inhibition of hypoxia-inducible factor (HIF) prolyl-hydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF- and CREB-independent pathways. J Neurosci 29(27):8828–38

pubmed: 19587290 pmcid: 3290095 doi: 10.1523/JNEUROSCI.1779-09.2009

Neitemeier S, Dolga AM, Honrath B, Karuppagounder SS, Alim I, Ratan RR et al (2016) Inhibition of HIF-prolyl-4-hydroxylases prevents mitochondrial impairment and cell death in a model of neuronal oxytosis. Cell Death Dis 7(5):e2214

pubmed: 27148687 pmcid: 4917646 doi: 10.1038/cddis.2016.107

Aragones J, Schneider M, Van Geyte K, Fraisl P, Dresselaers T, Mazzone M et al (2008) Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 40(2):170–80

pubmed: 18176562 doi: 10.1038/ng.2007.62

Quaegebeur A, Segura I, Schmieder R, Verdegem D, Decimo I, Bifari F et al (2016) Deletion or inhibition of the oxygen sensor PHD1 protects against ischemic stroke via reprogramming of neuronal metabolism. Cell Metab 23(2):280–91

pubmed: 26774962 pmcid: 4880550 doi: 10.1016/j.cmet.2015.12.007

Chen RL, Nagel S, Papadakis M, Bishop T, Pollard P, Ratcliffe PJ et al (2012) Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice. J Physiol 590(16):4079–91

pubmed: 22615432 pmcid: 3476649 doi: 10.1113/jphysiol.2012.232884

Lieb ME, Menzies K, Moschella MC, Ni R, Taubman MB (2002) Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. Biochem Cell Biol 80(4):421–6

pubmed: 12234095 doi: 10.1139/o02-115

Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J (2003) HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J 22(16):4082–90

pubmed: 12912907 pmcid: 175782 doi: 10.1093/emboj/cdg392

Marxsen JH, Stengel P, Doege K, Heikkinen P, Jokilehto T, Wagner T et al (2004) Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J 381(Pt 3):761–7

pubmed: 15104534 pmcid: 1133886 doi: 10.1042/BJ20040620

Kunze R, Zhou W, Veltkamp R, Wielockx B, Breier G, Marti HH (2012) Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia. Stroke 43(10):2748–56

pubmed: 22933585 doi: 10.1161/STROKEAHA.112.669598

Segura I, Lange C, Knevels E, Moskalyuk A, Pulizzi R, Eelen G et al (2016) The oxygen sensor PHD2 controls dendritic spines and synapses via modification of filamin A. Cell Rep 14(11):2653–67

pubmed: 26972007 pmcid: 4805856 doi: 10.1016/j.celrep.2016.02.047

Fan S, Wang J, Yu G, Rong F, Zhang D, Xu C et al (2020) TET is targeted for proteasomal degradation by the PHD-pVHL pathway to reduce DNA hydroxymethylation. J Biol Chem 295(48):16299–313

pubmed: 32963106 pmcid: 7705310 doi: 10.1074/jbc.RA120.014538

Huo Z, Ye JC, Chen J, Lin X, Zhou ZN, Xu XR et al (2012) Prolyl hydroxylase domain protein 2 regulates the intracellular cyclic AMP level in cardiomyocytes through its interaction with phosphodiesterase 4D. Biochem Biophys Res Commun 427(1):73–9

pubmed: 22975349 doi: 10.1016/j.bbrc.2012.09.005

Yi Y, Mikhaylova O, Mamedova A, Bastola P, Biesiada J, Alshaikh E et al (2010) von Hippel-Lindau-dependent patterns of RNA polymerase II hydroxylation in human renal clear cell carcinomas. Clin Cancer Res 16(21):5142–52

pubmed: 20978146 pmcid: 2970636 doi: 10.1158/1078-0432.CCR-09-3416

Li L, Saliba P, Reischl S, Marti HH, Kunze R (2016) Neuronal deficiency of HIF prolyl 4-hydroxylase 2 in mice improves ischemic stroke recovery in an HIF dependent manner. Neurobiol Dis 91:221–35

pubmed: 27001147 doi: 10.1016/j.nbd.2016.03.018

Takeda K, Cowan A, Fong GH (2007) Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system. Circulation 116(7):774–81

pubmed: 17646578 doi: 10.1161/CIRCULATIONAHA.107.701516

Corcoran A, Kunze R, Harney SC, Breier G, Marti HH, O’Connor JJ (2013) A role for prolyl hydroxylase domain proteins in hippocampal synaptic plasticity. Hippocampus 23(10):861–72

pubmed: 23674383 doi: 10.1002/hipo.22142

Rohrbach S, Simm A, Pregla R, Franke C, Katschinski DM (2005) Age-dependent increase of prolyl-4-hydroxylase domain (PHD) 3 expression in human and mouse heart. Biogerontology 6(3):165–71

pubmed: 16041620 doi: 10.1007/s10522-005-7950-9

Koditz J, Nesper J, Wottawa M, Stiehl DP, Camenisch G, Franke C et al (2007) Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor. Blood 110(10):3610–7

pubmed: 17684156 doi: 10.1182/blood-2007-06-094441

Takeda K, Aguila HL, Parikh NS, Li X, Lamothe K, Duan LJ et al (2008) Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Blood 111(6):3229–35

pubmed: 18056838 pmcid: 2265459 doi: 10.1182/blood-2007-09-114561

Xie L, Xiao K, Whalen EJ, Forrester MT, Freeman RS, Fong G et al (2009) Oxygen-regulated beta(2)-adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL. Sci Signal 2(78):ra33

pubmed: 19584355 pmcid: 2788937 doi: 10.1126/scisignal.2000444

Rodriguez J, Herrero A, Li S, Rauch N, Quintanilla A, Wynne K et al (2018) PHD3 regulates p53 protein stability by hydroxylating proline 359. Cell Rep 24(5):1316–29

pubmed: 30067985 pmcid: 6088137 doi: 10.1016/j.celrep.2018.06.108

Xie L, Pi X, Mishra A, Fong G, Peng J, Patterson C (2012) PHD3-dependent hydroxylation of HCLK2 promotes the DNA damage response. J Clin Invest 122(8):2827–36

pubmed: 22797300 pmcid: 3408739 doi: 10.1172/JCI62374

Luo W, Hu H, Chang R, Zhong J, Knabel M, O’Meally R et al (2011) Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145(5):732–44

pubmed: 21620138 pmcid: 3130564 doi: 10.1016/j.cell.2011.03.054

Lange PS, Chavez JC, Pinto JT, Coppola G, Sun CW, Townes TM et al (2008) ATF4 is an oxidative stress-inducible, prodeath transcription factor in neurons in vitro and in vivo. J Exp Med 205(5):1227–42

pubmed: 18458112 pmcid: 2373852 doi: 10.1084/jem.20071460

Hiwatashi Y, Kanno K, Takasaki C, Goryo K, Sato T, Torii S et al (2011) PHD1 interacts with ATF4 and negatively regulates its transcriptional activity without prolyl hydroxylation. Exp Cell Res 317(20):2789–99

pubmed: 21951999 doi: 10.1016/j.yexcr.2011.09.005

Sato M, Sakota M, Nakayama K (2010) Human PRP19 interacts with prolyl-hydroxylase PHD3 and inhibits cell death in hypoxia. Exp Cell Res 316(17):2871–82

pubmed: 20599946 doi: 10.1016/j.yexcr.2010.06.018

Wong BW, Kuchnio A, Bruning U, Carmeliet P (2013) Emerging novel functions of the oxygen-sensing prolyl hydroxylase domain enzymes. Trends Biochem Sci 38(1):3–11

pubmed: 23200187 doi: 10.1016/j.tibs.2012.10.004

Lee S, Nakamura E, Yang H, Wei W, Linggi MS, Sajan MP et al (2005) Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8(2):155–67

pubmed: 16098468 doi: 10.1016/j.ccr.2005.06.015

Bishop T, Gallagher D, Pascual A, Lygate CA, de Bono JP, Nicholls LG et al (2008) Abnormal sympathoadrenal development and systemic hypotension in PHD3-/- mice. Mol Cell Biol 28(10):3386–400

pubmed: 18332118 pmcid: 2423159 doi: 10.1128/MCB.02041-07

Li F, Yin C, Ma Z, Yang K, Sun L, Duan C et al (2021) PHD3 mediates denervation skeletal muscle atrophy through Nf-kappaB signal pathway. FASEB J 35(4):e21444

pubmed: 33749901 doi: 10.1096/fj.202002049R

Xie L, Pi X, Wang Z, He J, Willis MS, Patterson C (2015) Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis. J Mol Cell Cardiol 80:156–65

pubmed: 25633836 pmcid: 4374643 doi: 10.1016/j.yjmcc.2015.01.007

Oehme F, Ellinghaus P, Kolkhof P, Smith TJ, Ramakrishnan S, Hutter J et al (2002) Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors. Biochem Biophys Res Commun 296(2):343–9

pubmed: 12163023 doi: 10.1016/S0006-291X(02)00862-8

Koivunen P, Tiainen P, Hyvarinen J, Williams KE, Sormunen R, Klaus SJ et al (2007) An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor alpha. J Biol Chem 282(42):30544–52

pubmed: 17726031 doi: 10.1074/jbc.M704988200

Leinonen H, Rossi M, Salo AM, Tiainen P, Hyvarinen J, Pitkanen M et al (2016) Lack of P4H-TM in mice results in age-related retinal and renal alterations. Hum Mol Genet 25(17):3810–23

pubmed: 27466183 doi: 10.1093/hmg/ddw228

Laitala A, Aro E, Walkinshaw G, Maki JM, Rossi M, Heikkila M et al (2012) Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis. Blood 120(16):3336–44

pubmed: 22955912 doi: 10.1182/blood-2012-07-441824

Myllykoski M, Sutinen A, Koski MK, Kallio JP, Raasakka A, Myllyharju J et al (2021) Structure of transmembrane prolyl 4-hydroxylase reveals unique organization of EF and dioxygenase domains. J Biol Chem 296:100197

pubmed: 33334883 doi: 10.1074/jbc.RA120.016542

Maddirevula S, Ben-Omran T, AlMureikhi M, Eyaid W, Arabi H, Alkuraya H et al (2020) Further delineation of HIDEA syndrome. Am J Med Genet A 182(12):2999–3006

pubmed: 32965080 doi: 10.1002/ajmg.a.61885

Hyvarinen J, Parikka M, Sormunen R, Ramet M, Tryggvason K, Kivirikko KI et al (2010) Deficiency of a transmembrane prolyl 4-hydroxylase in the zebrafish leads to basement membrane defects and compromised kidney function. J Biol Chem 285(53):42023–32

pubmed: 20952382 pmcid: 3009928 doi: 10.1074/jbc.M110.145904

Leinonen H, Koivisto H, Lipponen HR, Matilainen A, Salo AM, Dimova EY et al (2019) Null mutation in P4h-tm leads to decreased fear and anxiety and increased social behavior in mice. Neuropharmacology 153:63–72

pubmed: 31029587 doi: 10.1016/j.neuropharm.2019.04.023

Byts N, Sharma S, Malm T, Kaakinen M, Korhonen P, Jaakkonen L et al (2022) Inactivation of mouse transmembrane prolyl 4-hydroxylase increases blood brain barrier permeability and ischemia-induced cerebral neuroinflammation. J Biol Chem 298(3):101721

pubmed: 35151685 pmcid: 8914383 doi: 10.1016/j.jbc.2022.101721

Kosyakovsky J, Fine JM, Frey WH 2nd, Hanson LR (2021) Mechanisms of intranasal deferoxamine in neurodegenerative and neurovascular disease. Pharmaceuticals (Basel) 14(2):95

Miao M, Wu M, Li Y, Zhang L, Jin Q, Fan J et al (2022) Clinical potential of hypoxia inducible factors prolyl hydroxylase inhibitors in treating nonanemic diseases. Front Pharmacol 13:837249

pubmed: 35281917 pmcid: 8908211 doi: 10.3389/fphar.2022.837249

Brigandi RA, Johnson B, Oei C, Westerman M, Olbina G, de Zoysa J et al (2016) A novel hypoxia-inducible factor-prolyl hydroxylase inhibitor (GSK1278863) for anemia in CKD: a 28-day, phase 2a randomized trial. Am J Kidney Dis 67(6):861–71

pubmed: 26827289 doi: 10.1053/j.ajkd.2015.11.021

Macdougall IC, Akizawa T, Berns JS, Bernhardt T, Krueger T (2019) Effects of molidustat in the treatment of anemia in CKD. Clin J Am Soc Nephrol 14(1):28–39

pubmed: 30559105 doi: 10.2215/CJN.02510218

Su K, Li Z, Yu Y, Zhang X (2020) The prolyl hydroxylase inhibitor roxadustat: paradigm in drug discovery and prospects for clinical application beyond anemia. Drug Discov Today 25(7):1262–9

pubmed: 32380083 doi: 10.1016/j.drudis.2020.04.017

Palmer C, Roberts RL, Bero C (1994) Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke 25(5):1039–45

pubmed: 8165675 doi: 10.1161/01.STR.25.5.1039

Davis S, Helfaer MA, Traystman RJ, Hurn PD (1997) Parallel antioxidant and antiexcitotoxic therapy improves outcome after incomplete global cerebral ischemia in dogs. Stroke 28(1):198–204; discussion -5

Mu D, Chang YS, Vexler ZS, Ferriero DM (2005) Hypoxia-inducible factor 1alpha and erythropoietin upregulation with deferoxamine salvage after neonatal stroke. Exp Neurol 195(2):407–15

pubmed: 16023639 doi: 10.1016/j.expneurol.2005.06.001

Siddiq A, Ayoub IA, Chavez JC, Aminova L, Shah S, LaManna JC et al (2005) Hypoxia-inducible factor prolyl 4-hydroxylase inhibition A target for neuroprotection in the central nervous system. J Biol Chem 280(50):41732–43

pubmed: 16227210 doi: 10.1074/jbc.M504963200

Baranova O, Miranda LF, Pichiule P, Dragatsis I, Johnson RS, Chavez JC (2007) Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci 27(23):6320–32

pubmed: 17554006 pmcid: 6672155 doi: 10.1523/JNEUROSCI.0449-07.2007

Shin JA, Kim YA, Kim HW, Kim HS, Lee KE, Kang JL et al (2018) Iron released from reactive microglia by noggin improves myelin repair in the ischemic brain. Neuropharmacology 133:202–15

pubmed: 29407213 doi: 10.1016/j.neuropharm.2018.01.038

Millan M, DeGregorio-Rocasolano N, Perez de la Ossa N, Reverte S, Costa J, Giner P et al (2021) Targeting pro-oxidant iron with deferoxamine as a treatment for ischemic stroke: safety and optimal dose selection in a randomized clinical trial. Antioxidants (Basel) 10(8):1270

Mahoney-Sanchez L, Bouchaoui H, Ayton S, Devos D, Duce JA, Devedjian JC (2021) Ferroptosis and its potential role in the physiopathology of Parkinson’s disease. Prog Neurobiol 196:101890

pubmed: 32726602 doi: 10.1016/j.pneurobio.2020.101890

Cunliffe CJ, Franklin TJ, Hales NJ, Hill GB (1992) Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analogue N-oxaloglycine and its derivatives. J Med Chem 35(14):2652–8

pubmed: 1321909 doi: 10.1021/jm00092a016

Mole DR, Schlemminger I, McNeill LA, Hewitson KS, Pugh CW, Ratcliffe PJ et al (2003) 2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase. Bioorg Med Chem Lett 13(16):2677–80

pubmed: 12873492 doi: 10.1016/S0960-894X(03)00539-0

Ogle ME, Gu X, Espinera AR, Wei L (2012) Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia inducible factor-1alpha. Neurobiol Dis 45(2):733–42

pubmed: 22061780 doi: 10.1016/j.nbd.2011.10.020

Buch S, Ye Y, Haacke EM (2017) Quantifying the changes in oxygen extraction fraction and cerebral activity caused by caffeine and acetazolamide. J Cereb Blood Flow Metab 37(3):825–36

pubmed: 27029391 doi: 10.1177/0271678X16641129

Smirnova NA, Rakhman I, Moroz N, Basso M, Payappilly J, Kazakov S et al (2010) Utilization of an in vivo reporter for high throughput identification of branched small molecule regulators of hypoxic adaptation. Chem Biol 17(4):380–91

pubmed: 20416509 pmcid: 4327942 doi: 10.1016/j.chembiol.2010.03.008

Li K, Li T, Wang Y, Xu Y, Zhang S, Culmsee C et al (2019) Sex differences in neonatal mouse brain injury after hypoxia-ischemia and adaptaquin treatment. J Neurochem 150(6):759–75

pubmed: 31188470 doi: 10.1111/jnc.14790

Nangaku M, Izuhara Y, Takizawa S, Yamashita T, Fujii-Kuriyama Y, Ohneda O et al (2007) A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia. Arterioscler Thromb Vasc Biol 27(12):2548–54

pubmed: 17932321 doi: 10.1161/ATVBAHA.107.148551

Chen RL, Ogunshola OO, Yeoh KK, Jani A, Papadakis M, Nagel S et al (2014) HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice. J Neurochem 131(2):177–89

pubmed: 24974727 doi: 10.1111/jnc.12804

Reischl S, Li L, Walkinshaw G, Flippin LA, Marti HH, Kunze R (2014) Inhibition of HIF prolyl-4-hydroxylases by FG-4497 reduces brain tissue injury and edema formation during ischemic stroke. PLoS ONE 9(1):e84767

pubmed: 24409307 pmcid: 3883663 doi: 10.1371/journal.pone.0084767

Zhou J, Li J, Rosenbaum DM, Zhuang J, Poon C, Qin P et al (2017) The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits. PLoS ONE 12(9):e0184049

pubmed: 28880966 pmcid: 5589177 doi: 10.1371/journal.pone.0184049

McMurray F, Demetriades M, Aik W, Merkestein M, Kramer H, Andrew DS et al (2015) Pharmacological inhibition of FTO. PLoS ONE 10(4):e0121829

pubmed: 25830347 pmcid: 4382163 doi: 10.1371/journal.pone.0121829

Yeh TL, Leissing TM, Abboud MI, Thinnes CC, Atasoylu O, Holt-Martyn JP et al (2017) Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials. Chem Sci 8(11):7651–68

pubmed: 29435217 pmcid: 5802278 doi: 10.1039/C7SC02103H

Gojkovic M, Cunha PP, Darmasaputra GS, Barbieri L, Rundqvist H, Velica P et al (2021) Oxygen-mediated suppression of CD8+ T cell proliferation by macrophages: role of pharmacological inhibitors of HIF degradation. Front Immunol 12:633586

pubmed: 34054802 pmcid: 8153186 doi: 10.3389/fimmu.2021.633586

Beneke A, Guentsch A, Hillemann A, Zieseniss A, Swain L, Katschinski DM (2017) Loss of PHD3 in myeloid cells dampens the inflammatory response and fibrosis after hind-limb ischemia. Cell Death Dis 8(8):e2976

pubmed: 28796258 pmcid: 5596563 doi: 10.1038/cddis.2017.375

Hoppe G, Yoon S, Gopalan B, Savage AR, Brown R, Case K et al (2016) Comparative systems pharmacology of HIF stabilization in the prevention of retinopathy of prematurity. Proc Natl Acad Sci U S A 113(18):E2516-25

pubmed: 27091985 pmcid: 4983815 doi: 10.1073/pnas.1523005113

Tan EY, Campo L, Han C, Turley H, Pezzella F, Gatter KC et al (2007) Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer. Breast Cancer Res 9(6):R89

pubmed: 18096060 pmcid: 2246192 doi: 10.1186/bcr1838

Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK (2002) FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16(12):1466–71

pubmed: 12080085 pmcid: 186346 doi: 10.1101/gad.991402

Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML (2002) Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295(5556):858–61

pubmed: 11823643 doi: 10.1126/science.1068592

Koivunen P, Hirsila M, Gunzler V, Kivirikko KI, Myllyharju J (2004) Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J Biol Chem 279(11):9899–904

pubmed: 14701857 doi: 10.1074/jbc.M312254200

Bullen JW, Tchernyshyov I, Holewinski RJ, DeVine L, Wu F, Venkatraman V et al (2016) Protein kinase A-dependent phosphorylation stimulates the transcriptional activity of hypoxia-inducible factor 1. Sci Signal. 9(430):ra56

pubmed: 27245613 pmcid: 5541497 doi: 10.1126/scisignal.aaf0583

Cockman ME, Lancaster DE, Stolze IP, Hewitson KS, McDonough MA, Coleman ML et al (2006) Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc Natl Acad Sci U S A 103(40):14767–72

pubmed: 17003112 pmcid: 1578504 doi: 10.1073/pnas.0606877103

Coleman ML, McDonough MA, Hewitson KS, Coles C, Mecinovic J, Edelmann M et al (2007) Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor. J Biol Chem 282(33):24027–38

pubmed: 17573339 doi: 10.1074/jbc.M704102200

Zheng X, Linke S, Dias JM, Zheng X, Gradin K, Wallis TP et al (2008) Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways. Proc Natl Acad Sci U S A 105(9):3368–73

pubmed: 18299578 pmcid: 2265116 doi: 10.1073/pnas.0711591105

Ferguson JE 3rd, Wu Y, Smith K, Charles P, Powers K, Wang H et al (2007) ASB4 is a hydroxylation substrate of FIH and promotes vascular differentiation via an oxygen-dependent mechanism. Mol Cell Biol 27(18):6407–19

pubmed: 17636018 pmcid: 2099627 doi: 10.1128/MCB.00511-07

Fukuba H, Takahashi T, Jin HG, Kohriyama T, Matsumoto M (2008) Abundance of aspargynyl-hydroxylase FIH is regulated by Siah-1 under normoxic conditions. Neurosci Lett 433(3):209–14

pubmed: 18280659 doi: 10.1016/j.neulet.2007.12.069

Martinez-Romero R, Canuelo A, Martinez-Lara E, Javier Oliver F, Cardenas S, Siles E (2009) Poly(ADP-ribose) polymerase-1 modulation of in vivo response of brain hypoxia-inducible factor-1 to hypoxia/reoxygenation is mediated by nitric oxide and factor inhibiting HIF. J Neurochem 111(1):150–9

pubmed: 19656264 doi: 10.1111/j.1471-4159.2009.06307.x

Zhang N, Fu Z, Linke S, Chicher J, Gorman JJ, Visk D et al (2010) The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism. Cell Metab 11(5):364–78

pubmed: 20399150 pmcid: 2893150 doi: 10.1016/j.cmet.2010.03.001

Cai X, Zhang D, Wang J, Liu X, Ouyang G, Xiao W (2018) Deletion of the fih gene encoding an inhibitor of hypoxia-inducible factors increases hypoxia tolerance in zebrafish. J Biol Chem 293(40):15370–80

pubmed: 30126845 pmcid: 6177605 doi: 10.1074/jbc.RA118.003004

Wu N, Zhang X, Du S, Chen D, Che R (2018) Upregulation of miR-335 ameliorates myocardial ischemia reperfusion injury via targeting hypoxia inducible factor 1-alpha subunit inhibitor. Am J Transl Res 10(12):4082–94

pubmed: 30662652 pmcid: 6325516

Davis CK, Nampoothiri SS, Rajanikant GK (2018) Folic acid exerts post-ischemic neuroprotection in vitro through HIF-1alpha stabilization. Mol Neurobiol 55(11):8328–45

pubmed: 29542054 doi: 10.1007/s12035-018-0982-3

Tang S, Liu D, Fang Y, Yong L, Zhang Y, Guan M et al (2023) Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer. Front Oncol 13:1080910

pubmed: 36816977 pmcid: 9932925 doi: 10.3389/fonc.2023.1080910

Wang E, Zhang C, Polavaram N, Liu F, Wu G, Schroeder MA et al (2014) The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme. PLoS ONE 9(1):e86102

pubmed: 24465898 pmcid: 3900478 doi: 10.1371/journal.pone.0086102

McDonough MA, McNeill LA, Tilliet M, Papamicael CA, Chen QY, Banerji B et al (2005) Selective inhibition of factor inhibiting hypoxia-inducible factor. J Am Chem Soc 127(21):7680–1

pubmed: 15913349 doi: 10.1021/ja050841b

Kanwal M, Smahel M, Olsen M, Smahelova J, Tachezy R (2020) Aspartate beta-hydroxylase as a target for cancer therapy. J Exp Clin Cancer Res 39(1):163

pubmed: 32811566 pmcid: 7433162 doi: 10.1186/s13046-020-01669-w

Sepe PS, Lahousse SA, Gemelli B, Chang H, Maeda T, Wands JR et al (2002) Role of the aspartyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell motility. Lab Invest 82(7):881–91

pubmed: 12118090 doi: 10.1097/01.LAB.0000020406.91689.7F

Zheng W, Wang X, Hu J, Bai B, Zhu H (2020) Diverse molecular functions of aspartate beta-hydroxylase in cancer (Review). Oncol Rep 44(6):2364–72

pubmed: 33125119 pmcid: 7610305 doi: 10.3892/or.2020.7792

Brewitz L, Tumber A, Schofield CJ (2020) Kinetic parameters of human aspartate/asparagine-beta-hydroxylase suggest that it has a possible function in oxygen sensing. J Biol Chem 295(23):7826–38

pubmed: 32107312 pmcid: 7278358 doi: 10.1074/jbc.RA119.012202

Lawton M, Tong M, Gundogan F, Wands JR, de la Monte SM (2010) Aspartyl-(asparaginyl) beta-hydroxylase, hypoxia-inducible factor-alpha and Notch cross-talk in regulating neuronal motility. Oxid Med Cell Longev 3(5):347–56

pubmed: 21150341 pmcid: 3154035 doi: 10.4161/oxim.3.5.13296

Silbermann E, Moskal P, Bowling N, Tong M, de la Monte SM (2010) Role of aspartyl-(asparaginyl)-beta-hydroxylase mediated notch signaling in cerebellar development and function. Behav Brain Funct 6:68

pubmed: 21050474 pmcid: 2988696 doi: 10.1186/1744-9081-6-68

Carter JJ, Tong M, Silbermann E, Lahousse SA, Ding FF, Longato L et al (2008) Ethanol impaired neuronal migration is associated with reduced aspartyl-asparaginyl-beta-hydroxylase expression. Acta Neuropathol 116(3):303–15

pubmed: 18478238 pmcid: 10010160 doi: 10.1007/s00401-008-0377-z

Brennan-Krohn T, Salloway S, Correia S, Dong M, de la Monte SM (2010) Glial vascular degeneration in CADASIL. J Alzheimers Dis 21(4):1393–402

pubmed: 21504125 pmcid: 3019271 doi: 10.3233/JAD-2010-100036

Huang X, Zhang L, Qi H, Shao J, Shen J (2013) Identification and functional implication of nuclear localization signals in the N-terminal domain of JMJD5. Biochimie 95(11):2114–22

pubmed: 23948433 doi: 10.1016/j.biochi.2013.08.002

Suzuki T, Minehata K, Akagi K, Jenkins NA, Copeland NG (2006) Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice. EMBO J 25(14):3422–31

pubmed: 16858412 pmcid: 1523184 doi: 10.1038/sj.emboj.7601215

Hsia DA, Tepper CG, Pochampalli MR, Hsia EY, Izumiya C, Huerta SB et al (2010) KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation. Proc Natl Acad Sci U S A 107(21):9671–6

pubmed: 20457893 pmcid: 2906833 doi: 10.1073/pnas.1000401107

Youn MY, Yokoyama A, Fujiyama-Nakamura S, Ohtake F, Minehata K, Yasuda H et al (2012) JMJD5, a Jumonji C (JmjC) domain-containing protein, negatively regulates osteoclastogenesis by facilitating NFATc1 protein degradation. J Biol Chem 287(16):12994–3004

pubmed: 22375008 pmcid: 3339979 doi: 10.1074/jbc.M111.323105

Oh S, Janknecht R (2012) Histone demethylase JMJD5 is essential for embryonic development. Biochem Biophys Res Commun 420(1):61–5

pubmed: 22402282 doi: 10.1016/j.bbrc.2012.02.115

Del Rizzo PA, Krishnan S, Trievel RC (2012) Crystal structure and functional analysis of JMJD5 indicate an alternate specificity and function. Mol Cell Biol 32(19):4044–52

pubmed: 22851697 pmcid: 3457536 doi: 10.1128/MCB.00513-12

Wilkins SE, Islam MS, Gannon JM, Markolovic S, Hopkinson RJ, Ge W et al (2018) JMJD5 is a human arginyl C-3 hydroxylase. Nat Commun 9(1):1180

pubmed: 29563586 pmcid: 5862942 doi: 10.1038/s41467-018-03410-w

Wang HJ, Hsieh YJ, Cheng WC, Lin CP, Lin YS, Yang SF et al (2014) JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1alpha-mediated glucose metabolism. Proc Natl Acad Sci U S A 111(1):279–84

pubmed: 24344305 doi: 10.1073/pnas.1311249111

Wang HJ, Pochampalli M, Wang LY, Zou JX, Li PS, Hsu SC et al (2019) KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC. Oncogene 38(1):17–32

pubmed: 30072740 doi: 10.1038/s41388-018-0414-x

Wang H, Wang J, Liu J, Wang Y, Xia G, Huang X (2022) Jumonji-C domain-containing protein 5 suppresses proliferation and aerobic glycolysis in pancreatic cancer cells in a c-Myc-dependent manner. Cell Signal 93:110282

pubmed: 35176452 doi: 10.1016/j.cellsig.2022.110282

Smith SM, Kimyon RS, Watters JJ (2014) Cell-type-specific Jumonji histone demethylase gene expression in the healthy rat CNS: detection by a novel flow cytometry method. ASN Neuro 6(3):193–207

pubmed: 24735454 doi: 10.1042/AN20130050

Iwasa N, Matsui TK, Iguchi N, Kinugawa K, Morikawa N, Sakaguchi YM et al (2021) Gene expression profiles of human cerebral organoids identify PPAR pathway and PKM2 as key markers for oxygen-glucose deprivation and reoxygenation. Front Cell Neurosci 15:605030

pubmed: 34168538 pmcid: 8217463 doi: 10.3389/fncel.2021.605030

Gao CL, Hou GG, Liu J, Ru T, Xu YZ, Zhao SY et al (2020) Synthesis and Target identification of benzoxepane derivatives as potential anti-neuroinflammatory agents for ischemic stroke. Angew Chem Int Ed Engl 59(6):2429–39

pubmed: 31782597 doi: 10.1002/anie.201912489

Dhanesha N, Patel RB, Doddapattar P, Ghatge M, Flora GD, Jain M et al (2022) PKM2 promotes neutrophil activation and cerebral thromboinflammation: therapeutic implications for ischemic stroke. Blood 139(8):1234–45

pubmed: 34529778 pmcid: 8874361 doi: 10.1182/blood.2021012322

Chen D, Wei L, Liu ZR, Yang JJ, Gu X, Wei ZZ et al (2018) Pyruvate kinase M2 increases angiogenesis, neurogenesis, and functional recovery mediated by upregulation of STAT3 and focal adhesion kinase activities after ischemic stroke in adult mice. Neurotherapeutics 15(3):770–84

pubmed: 29869055 pmcid: 6095793 doi: 10.1007/s13311-018-0635-2

Hughes BT, Espenshade PJ (2008) Oxygen-regulated degradation of fission yeast SREBP by Ofd1, a prolyl hydroxylase family member. EMBO J 27(10):1491–501

pubmed: 18418381 pmcid: 2396400

Loenarz C, Sekirnik R, Thalhammer A, Ge W, Spivakovsky E, Mackeen MM et al (2014) Hydroxylation of the eukaryotic ribosomal decoding center affects translational accuracy. Proc Natl Acad Sci U S A 111(11):4019–24

pubmed: 24550462 pmcid: 3964080 doi: 10.1073/pnas.1311750111

Katz MJ, Acevedo JM, Loenarz C, Galagovsky D, Liu-Yi P, Perez-Pepe M et al (2014) Sudestada1, a Drosophila ribosomal prolyl-hydroxylase required for mRNA translation, cell homeostasis, and organ growth. Proc Natl Acad Sci U S A 111(11):4025–30

pubmed: 24550463 pmcid: 3964085 doi: 10.1073/pnas.1314485111

Wehner KA, Schutz S, Sarnow P (2010) OGFOD1, a novel modulator of eukaryotic translation initiation factor 2alpha phosphorylation and the cellular response to stress. Mol Cell Biol 30(8):2006–16

pubmed: 20154146 pmcid: 2849474 doi: 10.1128/MCB.01350-09

Singleton RS, Liu-Yi P, Formenti F, Ge W, Sekirnik R, Fischer R et al (2014) OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation. Proc Natl Acad Sci U S A 111(11):4031–6

pubmed: 24550447 pmcid: 3964040 doi: 10.1073/pnas.1314482111

Lafita-Navarro MC, Kim M, Borenstein-Auerbach N, Venkateswaran N, Hao YH, Ray R et al (2018) The aryl hydrocarbon receptor regulates nucleolar activity and protein synthesis in MYC-expressing cells. Genes Dev 32(19–20):1303–8

pubmed: 30254109 pmcid: 6169836 doi: 10.1101/gad.313007.118

Stoehr A, Kennedy L, Yang Y, Patel S, Lin Y, Linask KL et al (2019) The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation and modulates translation and splicing. JCI Insight 5(13):e128496

Saito K, Adachi N, Koyama H, Matsushita M (2010) OGFOD1, a member of the 2-oxoglutarate and iron dependent dioxygenase family, functions in ischemic signaling. FEBS Lett 584(15):3340–7

pubmed: 20579638 doi: 10.1016/j.febslet.2010.06.015

Harris M, Sun J, Keeran K, Aponte A, Singh K, Springer D et al (2022) Ogfod1 deletion increases cardiac beta-alanine levels and protects mice against ischaemia- reperfusion injury. Cardiovasc Res 118(13):2847–58

pubmed: 34668514 doi: 10.1093/cvr/cvab323

Quadri M, Yang X, Cossu G, Olgiati S, Saddi VM, Breedveld GJ et al (2015) An exome study of Parkinson’s disease in Sardinia, a Mediterranean genetic isolate. Neurogenetics 16(1):55–64

pubmed: 25294124 doi: 10.1007/s10048-014-0425-x

Horita S, Scotti JS, Thinnes C, Mottaghi-Taromsari YS, Thalhammer A, Ge W et al (2015) Structure of the ribosomal oxygenase OGFOD1 provides insights into the regio- and stereoselectivity of prolyl hydroxylases. Structure 23(4):639–52

pubmed: 25728928 pmcid: 4396695 doi: 10.1016/j.str.2015.01.014

Thinnes CC, Lohans CT, Abboud MI, Yeh TL, Tumber A, Nowak RP et al (2019) Selective inhibitors of a human prolyl hydroxylase (OGFOD1) involved in ribosomal decoding. Chemistry 25(8):2019–24

pubmed: 30427558 pmcid: 6471485 doi: 10.1002/chem.201804790

Chang W, Barnes AM, Cabral WA, Bodurtha JN, Marini JC (2010) Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic reticulum collagen prolyl 3-hydroxylation complex. Hum Mol Genet 19(2):223–34

pubmed: 19846465 doi: 10.1093/hmg/ddp481

Tiainen P, Pasanen A, Sormunen R, Myllyharju J (2008) Characterization of recombinant human prolyl 3-hydroxylase isoenzyme 2, an enzyme modifying the basement membrane collagen IV. J Biol Chem 283(28):19432–9

pubmed: 18487197 doi: 10.1074/jbc.M802973200

Annunen P, Autio-Harmainen H, Kivirikko KI (1998) The novel type II prolyl 4-hydroxylase is the main enzyme form in chondrocytes and capillary endothelial cells, whereas the type I enzyme predominates in most cells. J Biol Chem 273(11):5989–92

pubmed: 9497309 doi: 10.1074/jbc.273.11.5989

Roet KC, Franssen EH, de Bree FM, Essing AH, Zijlstra SJ, Fagoe ND et al (2013) A multilevel screening strategy defines a molecular fingerprint of proregenerative olfactory ensheathing cells and identifies SCARB2, a protein that improves regenerative sprouting of injured sensory spinal axons. J Neurosci 33(27):11116–35

pubmed: 23825416 pmcid: 6618611 doi: 10.1523/JNEUROSCI.1002-13.2013

Pignata P, Apicella I, Cicatiello V, Puglisi C, Magliacane Trotta S, Sanges R et al (2021) Prolyl 3-hydroxylase 2 is a molecular player of angiogenesis. Int J Mol Sci 22(8):3896

Zhang J, Dong Y, Shi Z, He H, Chen J, Zhang S et al (2022) P3H4 and PLOD1 expression associates with poor prognosis in bladder cancer. Clin Transl Oncol 24(8):1524–32

pubmed: 35149972 doi: 10.1007/s12094-022-02791-1

Vranka J, Stadler HS, Bachinger HP (2009) Expression of prolyl 3-hydroxylase genes in embryonic and adult mouse tissues. Cell Struct Funct 34(2):97–104

pubmed: 19652424 doi: 10.1247/csf.09002

Kivirikko KI, Myllyla R, Pihlajaniemi T (1989) Protein hydroxylation: prolyl 4-hydroxylase, an enzyme with four cosubstrates and a multifunctional subunit. FASEB J 3(5):1609–17

pubmed: 2537773 doi: 10.1096/fasebj.3.5.2537773

Vranka JA, Sakai LY, Bachinger HP (2004) Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes. J Biol Chem 279(22):23615–21

pubmed: 15044469 doi: 10.1074/jbc.M312807200

Gilkes DM, Bajpai S, Chaturvedi P, Wirtz D, Semenza GL (2013) Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts. J Biol Chem 288(15):10819–29

pubmed: 23423382 pmcid: 3624462 doi: 10.1074/jbc.M112.442939

Balamurugan K (2016) HIF-1 at the crossroads of hypoxia, inflammation, and cancer. Int J Cancer 138(5):1058–66

pubmed: 25784597 doi: 10.1002/ijc.29519

Xiong G, Stewart RL, Chen J, Gao T, Scott TL, Samayoa LM et al (2018) Collagen prolyl 4-hydroxylase 1 is essential for HIF-1alpha stabilization and TNBC chemoresistance. Nat Commun 9(1):4456

pubmed: 30367042 pmcid: 6203834 doi: 10.1038/s41467-018-06893-9

Zhou Y, Jin G, Mi R, Zhang J, Zhang J, Xu H et al (2017) Knockdown of P4HA1 inhibits neovascularization via targeting glioma stem cell-endothelial cell transdifferentiation and disrupting vascular basement membrane. Oncotarget 8(22):35877–89

pubmed: 28415787 pmcid: 5482624 doi: 10.18632/oncotarget.16270

Fu Y, Bao Q, Liu Z, He G, Wen J, Liu Q et al (2021) Development and validation of a hypoxia-associated prognostic signature related to osteosarcoma metastasis and immune infiltration. Front Cell Dev Biol 9:633607

pubmed: 33816483 pmcid: 8012854 doi: 10.3389/fcell.2021.633607

Eriksson J, Le Joncour V, Jahkola T, Juteau S, Laakkonen P, Saksela O et al (2020) Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas, and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls. Mol Oncol 14(4):742–62

pubmed: 32053263 pmcid: 7138405 doi: 10.1002/1878-0261.12649

Hu WM, Zhang J, Sun SX, Xi SY, Chen ZJ, Jiang XB et al (2017) Identification of P4HA1 as a prognostic biomarker for high-grade gliomas. Pathol Res Pract 213(11):1365–9

pubmed: 28964577 doi: 10.1016/j.prp.2017.09.017

Li H, Li J, Jiang X, Liu S, Liu Y, Chen W et al (2019) Melatonin enhances atherosclerotic plaque stability by inducing prolyl-4-hydroxylase alpha1 expression. J Hypertens 37(5):964–71

pubmed: 30335670 doi: 10.1097/HJH.0000000000001979

Shi R, Gao S, Smith AH, Li H, Shao M, Shangguan J et al (2020) Superoxide-induced type I collagen secretion depends on prolyl 4-hydroxylases. Biochem Biophys Res Commun 529(4):1011–7

pubmed: 32819558 pmcid: 7442856 doi: 10.1016/j.bbrc.2020.07.002

Edwards DN, Bix GJ (2019) Roles of blood-brain barrier integrins and extracellular matrix in stroke. Am J Physiol Cell Physiol 316(2):C252–C63

pubmed: 30462535 doi: 10.1152/ajpcell.00151.2018

Hatakeyama M, Ninomiya I, Kanazawa M (2020) Angiogenesis and neuronal remodeling after ischemic stroke. Neural Regen Res 15(1):16–9

pubmed: 31535636 doi: 10.4103/1673-5374.264442

Qi Y, Xu R (2018) Roles of PLODs in collagen synthesis and cancer progression. Front Cell Dev Biol 6:66

pubmed: 30003082 pmcid: 6031748 doi: 10.3389/fcell.2018.00066

Hofbauer KH, Gess B, Lohaus C, Meyer HE, Katschinski D, Kurtz A (2003) Oxygen tension regulates the expression of a group of procollagen hydroxylases. Eur J Biochem 270(22):4515–22

pubmed: 14622280 doi: 10.1046/j.1432-1033.2003.03846.x

Song Y, Zheng S, Wang J, Long H, Fang L, Wang G et al (2017) Hypoxia-induced PLOD2 promotes proliferation, migration and invasion via PI3K/Akt signaling in glioma. Oncotarget 8(26):41947–62

pubmed: 28410212 pmcid: 5522040 doi: 10.18632/oncotarget.16710

Kresse N, Schroder H, Stein KP, Wilkens L, Mawrin C, Sandalcioglu IE et al (2022) PLOD2 Is a Prognostic marker in glioblastoma that modulates the immune microenvironment and tumor progression. Int J Mol Sci 23(11):6037

Baek JH, Yun HS, Kwon GT, Lee J, Kim JY, Jo Y et al (2019) PLOD3 suppression exerts an anti-tumor effect on human lung cancer cells by modulating the PKC-delta signaling pathway. Cell Death Dis 10(3):156

pubmed: 30770789 pmcid: 6377650 doi: 10.1038/s41419-019-1405-8

Brinckmann J, Acil Y, Feshchenko S, Katzer E, Brenner R, Kulozik A et al (1998) Ehlers-Danlos syndrome type VI: lysyl hydroxylase deficiency due to a novel point mutation (W612C). Arch Dermatol Res 290(4):181–6

pubmed: 9617436 doi: 10.1007/s004030050287

Neyazi B, Tanrikulu L, Wilkens L, Hartmann C, Stein KP, Dumitru CA et al (2017) Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 expression in brain arteriovenous malformations and its association with brain arteriovenous malformation size. World Neurosurg 102:79–84

pubmed: 28279775 doi: 10.1016/j.wneu.2017.02.116

Jover E, Silvente A, Marin F, Martinez-Gonzalez J, Orriols M, Martinez CM et al (2018) Inhibition of enzymes involved in collagen cross-linking reduces vascular smooth muscle cell calcification. FASEB J 32(8):4459–69

pubmed: 29547702 doi: 10.1096/fj.201700653R

Yoo H, Son D, Lee YJ, Hong K (2016) Mouse JMJD4 is dispensable for embryogenesis. Mol Reprod Dev 83(7):588–93

pubmed: 27147518 doi: 10.1002/mrd.22654

Feng T, Yamamoto A, Wilkins SE, Sokolova E, Yates LA, Munzel M et al (2014) Optimal translational termination requires C4 lysyl hydroxylation of eRF1. Mol Cell 53(4):645–54

pubmed: 24486019 pmcid: 3991326 doi: 10.1016/j.molcel.2013.12.028

Blanchet S, Rowe M, Von der Haar T, Fabret C, Demais S, Howard MJ et al (2015) New insights into stop codon recognition by eRF1. Nucleic Acids Res 43(6):3298–308

pubmed: 25735746 pmcid: 4381064 doi: 10.1093/nar/gkv154

Si W, Li Y, Ye S, Li Z, Liu Y, Kuang W et al (2020) Methyltransferase 3 mediated miRNA m6A methylation promotes stress granule formation in the early stage of acute ischemic stroke. Front Mol Neurosci 13:103

pubmed: 32581712 pmcid: 7289951 doi: 10.3389/fnmol.2020.00103

Zhou J, Simon JM, Liao C, Zhang C, Hu L, Zurlo G et al (2022) An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma. Mol Cell 82(16):3030–44 e8

Wan J, Liu H, Yang L, Ma L, Liu J, Ming L (2019) JMJD6 promotes hepatocellular carcinoma carcinogenesis by targeting CDK4. Int J Cancer 144(10):2489–500

pubmed: 30125344 doi: 10.1002/ijc.31816

Oh S, Shin S, Janknecht R (2019) The small members of the JMJD protein family: Enzymatic jewels or jinxes? Biochim Biophys Acta Rev Cancer 1871(2):406–18

pubmed: 31034925 pmcid: 6525012 doi: 10.1016/j.bbcan.2019.04.002

Cockman ME, Sugimoto Y, Pegg HB, Masson N, Salah E, Tumber A et al (2022) Widespread hydroxylation of unstructured lysine-rich protein domains by JMJD6. Proc Natl Acad Sci U S A 119(32):e2201483119

pubmed: 35930668 pmcid: 9371714 doi: 10.1073/pnas.2201483119

Haque F, Honjo T, Begum NA (2022) XLID syndrome gene Med12 promotes Ig isotype switching through chromatin modification and enhancer RNA regulation. Sci Adv 8(47):eadd1466

pubmed: 36427307 pmcid: 9699684 doi: 10.1126/sciadv.add1466

Zhou DX, Zhou D, Zhan SQ, Wang P, Qin K, Gan W et al (2017) Inhibition of JMJD6 expression reduces the proliferation, migration and invasion of neuroglioma stem cells. Neoplasma 64(5):700–8

pubmed: 28592121 doi: 10.4149/neo_2017_507

Alahari S, Post M, Rolfo A, Weksberg R, Caniggia I (2018) Compromised JMJD6 histone demethylase activity affects VHL gene repression in preeclampsia. J Clin Endocrinol Metab 103(4):1545–57

pubmed: 29373688 doi: 10.1210/jc.2017-02197

Alahari S, Post M, Caniggia I (2015) Jumonji domain containing protein 6: a novel oxygen sensor in the human placenta. Endocrinology 156(8):3012–25

pubmed: 26037477 doi: 10.1210/en.2015-1262

Lawson H, Sepulveda C, van de Lagemaat LN, Durko J, Barile M, Tavosanis A et al (2021) JMJD6 promotes self-renewal and regenerative capacity of hematopoietic stem cells. Blood Adv 5(3):889–99

pubmed: 33560400 pmcid: 7876897 doi: 10.1182/bloodadvances.2020002702

Chowdhury R, Abboud MI, Wiley J, Tumber A, Markolovic S, Schofield CJ (2022) Conservation of the unusual dimeric JmjC fold of JMJD7 from Drosophila melanogaster to humans. Sci Rep 12(1):6065

pubmed: 35410347 pmcid: 9001643 doi: 10.1038/s41598-022-10028-y

Matsunami N, Hensel CH, Baird L, Stevens J, Otterud B, Leppert T et al (2014) Identification of rare DNA sequence variants in high-risk autism families and their prevalence in a large case/control population. Mol Autism 5(1):5

pubmed: 24467814 pmcid: 4098669 doi: 10.1186/2040-2392-5-5

Markolovic S, Zhuang Q, Wilkins SE, Eaton CD, Abboud MI, Katz MJ et al (2018) The Jumonji-C oxygenase JMJD7 catalyzes (3S)-lysyl hydroxylation of TRAFAC GTPases. Nat Chem Biol 14(7):688–95

pubmed: 29915238 pmcid: 6027965 doi: 10.1038/s41589-018-0071-y

Liu H, Wang C, Lee S, Deng Y, Wither M, Oh S et al (2017) Clipping of arginine-methylated histone tails by JMJD5 and JMJD7. Proc Natl Acad Sci U S A 114(37):E7717–E26

pubmed: 28847961 pmcid: 5604019 doi: 10.1073/pnas.1706831114

Liu H, Wang C, Lee S, Ning F, Wang Y, Zhang Q et al (2018) Specific recognition of arginine methylated histone tails by JMJD5 and JMJD7. Sci Rep 8(1):3275

pubmed: 29459673 pmcid: 5818494 doi: 10.1038/s41598-018-21432-8

Wen Y, Shang Y, Wang Q (2022) Exploration of the mechanism of linoleic acid metabolism dysregulation in metabolic syndrome. Genet Res 2022:6793346 (Camb)

doi: 10.1155/2022/6793346

Chowdhury R, Sekirnik R, Brissett NC, Krojer T, Ho CH, Ng SS et al (2014) Ribosomal oxygenases are structurally conserved from prokaryotes to humans. Nature 510(7505):422–6

pubmed: 24814345 pmcid: 4066111 doi: 10.1038/nature13263

Brauer KE, Brockers K, Moneer J, Feuchtinger A, Wollscheid-Lengeling E, Lengeling A et al (2018) Phylogenetic and genomic analyses of the ribosomal oxygenases Riox1 (No66) and Riox2 (Mina53) provide new insights into their evolution. BMC Evol Biol 18(1):96

pubmed: 29914368 pmcid: 6006756 doi: 10.1186/s12862-018-1215-0

Ge W, Wolf A, Feng T, Ho CH, Sekirnik R, Zayer A et al (2012) Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans. Nat Chem Biol 8(12):960–2

pubmed: 23103944 pmcid: 4972389 doi: 10.1038/nchembio.1093

Sinha KM, Yasuda H, Coombes MM, Dent SY, de Crombrugghe B (2010) Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase. EMBO J 29(1):68–79

pubmed: 19927124 doi: 10.1038/emboj.2009.332

Lu Y, Chang Q, Zhang Y, Beezhold K, Rojanasakul Y, Zhao H et al (2009) Lung cancer-associated JmjC domain protein mdig suppresses formation of tri-methyl lysine 9 of histone H3. Cell Cycle 8(13):2101–9

pubmed: 19502796 doi: 10.4161/cc.8.13.8927

Sinha KM, Bagheri-Yarmand R, Lahiri S, Lu Y, Zhang M, Amra S et al (2019) Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer. Oncogene 38(25):5038–49

pubmed: 30858546 doi: 10.1038/s41388-019-0774-x

Fujino S, Kinugasa T, Sudo T, Mizobe T, Yoshida T, Yoshida N et al (2018) Mina53 nuclear localization is an important indicator of prognosis in patients with colorectal cancer after adjuvant chemotherapy. Oncol Rep 40(1):101–10

pubmed: 29750310

Greer EL, Shi Y (2012) Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet 13(5):343–57

pubmed: 22473383 pmcid: 4073795 doi: 10.1038/nrg3173

Burgold T, Voituron N, Caganova M, Tripathi PP, Menuet C, Tusi BK et al (2012) The H3K27 demethylase JMJD3 is required for maintenance of the embryonic respiratory neuronal network, neonatal breathing, and survival. Cell Rep 2(5):1244–58

pubmed: 23103168 doi: 10.1016/j.celrep.2012.09.013

Przanowski P, Dabrowski M, Ellert-Miklaszewska A, Kloss M, Mieczkowski J, Kaza B et al (2014) The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia. J Mol Med 92(3):239–54 (Berl)

pubmed: 24097101 doi: 10.1007/s00109-013-1090-5

Wu G, Zhang X, Li S, Wang L, Bai J, Wang H et al (2022) Silencing ATF4 inhibits JMJD3-dependent JUNB/ETS1 axis and mitigates cerebral ischemic injury. J Biochem Mol Toxicol 36(7):e23070

pubmed: 35403324 doi: 10.1002/jbt.23070

Feng P, Zhang A, Su M, Cai H, Wang X, Zhang Y (2021) Dexmedetomidine inhibits apoptosis of astrocytes induced by oxygen-glucose deprivation via targeting JAK/STAT3 signal pathway. Brain Res 1750:147141

pubmed: 33017590 doi: 10.1016/j.brainres.2020.147141

Zhang H, Wang J, Huang J, Shi T, Ma X, Luo X et al (2018) Inhibiting Jumoji domain containing protein 3 (JMJD3) prevent neuronal apoptosis from stroke. Exp Neurol 308:132–42

pubmed: 30028997 doi: 10.1016/j.expneurol.2018.07.007

Na W, Shin JY, Lee JY, Jeong S, Kim WS, Yune TY et al (2017) Dexamethasone suppresses JMJD3 gene activation via a putative negative glucocorticoid response element and maintains integrity of tight junctions in brain microvascular endothelial cells. J Cereb Blood Flow Metab 37(12):3695–708

pubmed: 28338398 pmcid: 5718327 doi: 10.1177/0271678X17701156

Kruidenier L, Chung CW, Cheng Z, Liddle J, Che K, Joberty G et al (2012) A selective Jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 488(7411):404–8

pubmed: 22842901 pmcid: 4691848 doi: 10.1038/nature11262

Xu J, Deng X, Watkins R, Disteche CM (2008) Sex-specific differences in expression of histone demethylases Utx and Uty in mouse brain and neurons. J Neurosci 28(17):4521–7

pubmed: 18434530 pmcid: 2643472 doi: 10.1523/JNEUROSCI.5382-07.2008

Qi S, Al Mamun A, Ngwa C, Romana S, Ritzel R, Arnold AP et al (2021) X chromosome escapee genes are involved in ischemic sexual dimorphism through epigenetic modification of inflammatory signals. J Neuroinflammation 18(1):70

pubmed: 33712031 pmcid: 7953638 doi: 10.1186/s12974-021-02120-3

Cai J, Yang Y, Han J, Gao Y, Li X, Ge X (2023) KDM4A, involved in the inflammatory and oxidative stress caused by traumatic brain injury-hemorrhagic shock, partly through the regulation of the microglia M1 polarization. BMC Neurosci 24(1):17

pubmed: 36869312 pmcid: 9983262 doi: 10.1186/s12868-023-00784-6

Liu Y, Zhao L, Zhang J, Lv L, Han K, Huang C et al (2021) Histone demethylase KDM4A inhibition represses neuroinflammation and improves functional recovery in ischemic stroke. Curr Pharm Des 27(21):2528–36

pubmed: 33402077 doi: 10.2174/1381612827666210105124529

Liu K, Zhu R, Jiang H, Li B, Geng Q, Li Y et al (2022) Taurine inhibits KDM3a production and microglia activation in lipopolysaccharide-treated mice and BV-2 cells. Mol Cell Neurosci 122:103759

pubmed: 35901929 doi: 10.1016/j.mcn.2022.103759

Gao J, Guo Y, Liu Y, Yan J, Zhou J, An X et al (2020) Protective effect of FBXL10 in myocardial ischemia reperfusion injury via inhibiting endoplasmic reticulum stress. Respir Med 161:105852

pubmed: 32056726 doi: 10.1016/j.rmed.2019.105852

Wei Z, Luo L, Hu S, Tian R, Liu Z (2022) KDM2B overexpression prevents myocardial ischemia-reperfusion injury in rats through regulating inflammatory response via the TLR4/NF-kappaB p65 axis. Exp Ther Med 23(2):154

pubmed: 35069835 doi: 10.3892/etm.2021.11077

Li SH, Chen L, Pang XM, Su SY, Zhou X, Chen CY et al (2017) Decreased miR-146a expression in acute ischemic stroke directly targets the Fbxl10 mRNA and is involved in modulating apoptosis. Neurochem Int 107:156–67

pubmed: 28202285 doi: 10.1016/j.neuint.2017.01.011

Tang QY, Zhang SF, Dai SK, Liu C, Wang YY, Du HZ et al (2020) UTX regulates human neural differentiation and dendritic morphology by resolving bivalent promoters. Stem Cell Rep 15(2):439–53

doi: 10.1016/j.stemcr.2020.06.015

Lei X, Jiao J (2018) UTX affects neural stem cell proliferation and differentiation through PTEN signaling. Stem Cell Rep 10(4):1193–207

doi: 10.1016/j.stemcr.2018.02.008

Tang GB, Zeng YQ, Liu PP, Mi TW, Zhang SF, Dai SK et al (2017) The histone H3K27 demethylase UTX regulates synaptic plasticity and cognitive behaviors in mice. Front Mol Neurosci 10:267

pubmed: 28970783 pmcid: 5609596 doi: 10.3389/fnmol.2017.00267

Miyake N, Mizuno S, Okamoto N, Ohashi H, Shiina M, Ogata K et al (2013) KDM6A point mutations cause Kabuki syndrome. Hum Mutat 34(1):108–10

pubmed: 23076834 doi: 10.1002/humu.22229

Park DH, Hong SJ, Salinas RD, Liu SJ, Sun SW, Sgualdino J et al (2014) Activation of neuronal gene expression by the JMJD3 demethylase is required for postnatal and adult brain neurogenesis. Cell Rep 8(5):1290–9

pubmed: 25176653 pmcid: 4201382 doi: 10.1016/j.celrep.2014.07.060

Fukuda T, Tokunaga A, Sakamoto R, Yoshida N (2011) Fbxl10/Kdm2b deficiency accelerates neural progenitor cell death and leads to exencephaly. Mol Cell Neurosci 46(3):614–24

pubmed: 21220025 doi: 10.1016/j.mcn.2011.01.001

Vallianatos CN, Iwase S (2015) Disrupted intricacy of histone H3K4 methylation in neurodevelopmental disorders. Epigenomics 7(3):503–19

pubmed: 26077434 doi: 10.2217/epi.15.1

Duncan AR, Vitobello A, Collins SC, Vancollie VE, Lelliott CJ, Rodan L et al (2020) Heterozygous variants in KDM4B lead to global developmental delay and neuroanatomical defects. Am J Hum Genet 107(6):1170–7

pubmed: 33232677 pmcid: 7820620 doi: 10.1016/j.ajhg.2020.11.001

Qi HH, Sarkissian M, Hu GQ, Wang Z, Bhattacharjee A, Gordon DB et al (2010) Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development. Nature 466(7305):503–7

pubmed: 20622853 pmcid: 3072215 doi: 10.1038/nature09261

Das ND, Choi MR, Jung KH, Park JH, Lee HT, Das A et al (2013) Functional analysis of histone demethylase Jmjd2b on lipopolysaccharide-treated murine neural stem cells (NSCs). Neurotox Res 23(2):154–65

pubmed: 22890720 doi: 10.1007/s12640-012-9346-3

Westbye MP, Feyzi E, Aas PA, Vagbo CB, Talstad VA, Kavli B et al (2008) Human AlkB homolog 1 is a mitochondrial protein that demethylates 3-methylcytosine in DNA and RNA. J Biol Chem 283(36):25046–56

pubmed: 18603530 pmcid: 3259822 doi: 10.1074/jbc.M803776200

Bian K, Lenz SAP, Tang Q, Chen F, Qi R, Jost M et al (2019) DNA repair enzymes ALKBH2, ALKBH3, and AlkB oxidize 5-methylcytosine to 5-hydroxymethylcytosine, 5-formylcytosine and 5-carboxylcytosine in vitro. Nucleic Acids Res 47(11):5522–9

pubmed: 31114894 pmcid: 6582317 doi: 10.1093/nar/gkz395

Ma CJ, Ding JH, Ye TT, Yuan BF, Feng YQ (2019) AlkB homologue 1 demethylates N(3)-methylcytidine in mRNA of mammals. ACS Chem Biol 14(7):1418–25

pubmed: 31188562 doi: 10.1021/acschembio.8b01001

Fu D, Brophy JA, Chan CT, Atmore KA, Begley U, Paules RS et al (2010) Human AlkB homolog ABH8 is a tRNA methyltransferase required for wobble uridine modification and DNA damage survival. Mol Cell Biol 30(10):2449–59

pubmed: 20308323 pmcid: 2863699 doi: 10.1128/MCB.01604-09

Ougland R, Rognes T, Klungland A, Larsen E (2015) Non-homologous functions of the AlkB homologs. J Mol Cell Biol 7(6):494–504

pubmed: 26003568 doi: 10.1093/jmcb/mjv029

Zhang X, Wei LH, Wang Y, Xiao Y, Liu J, Zhang W et al (2019) Structural insights into FTO’s catalytic mechanism for the demethylation of multiple RNA substrates. Proc Natl Acad Sci U S A 116(8):2919–24

pubmed: 30718435 pmcid: 6386707 doi: 10.1073/pnas.1820574116

Xiao MZ, Liu JM, Xian CL, Chen KY, Liu ZQ, Cheng YY (2020) Therapeutic potential of ALKB homologs for cardiovascular disease. Biomed Pharmacother 131:110645

pubmed: 32942149 doi: 10.1016/j.biopha.2020.110645

Bian EB, Zong G, Xie YS, Meng XM, Huang C, Li J et al (2014) TET family proteins: new players in gliomas. J Neurooncol 116(3):429–35

pubmed: 24395347 doi: 10.1007/s11060-013-1328-7

Saad AK, Marafi D, Mitani T, Du H, Rafat K, Fatih JM et al (2021) Neurodevelopmental disorder in an Egyptian family with a biallelic ALKBH8 variant. Am J Med Genet A 185(4):1288–93

pubmed: 33544954 pmcid: 8450764 doi: 10.1002/ajmg.a.62100

Kawarada L, Fukaya M, Saito R, Kassai H, Sakagami H, Aiba A (2021) Telencephalon-specific Alkbh1 conditional knockout mice display hippocampal atrophy and impaired learning. FEBS Lett 595(12):1671–80

pubmed: 33930188 doi: 10.1002/1873-3468.14098

Cetica V, Genitori L, Giunti L, Sanzo M, Bernini G, Massimino M et al (2009) Pediatric brain tumors: mutations of two dioxygenases (hABH2 and hABH3) that directly repair alkylation damage. J Neurooncol 94(2):195–201

pubmed: 19290481 doi: 10.1007/s11060-009-9837-0

Johannessen TC, Prestegarden L, Grudic A, Hegi ME, Tysnes BB, Bjerkvig R (2013) The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells. Neuro Oncol 15(3):269–78

pubmed: 23258843 doi: 10.1093/neuonc/nos301

Zhang C, Li X, Zhao L, Liang R, Deng W, Guo W et al (2022) Comprehensive and integrative analyses identify TYW5 as a schizophrenia risk gene. BMC Med 20(1):169

pubmed: 35527273 pmcid: 9082878 doi: 10.1186/s12916-022-02363-8

Thomas JL, Bruzzone R, El-Osta A, Claessens F, Ruysschaert JM, Wilson DM 3rd (2022) Tribute to Klaus Eichmann, Editor-in-Chief of Cellular and Molecular Life Sciences. Cell Mol Life Sci 79(10):529

pubmed: 36166158 doi: 10.1007/s00018-022-04532-7

Jessop P, Toledo-Rodriguez M (2018) Hippocampal TET1 and TET2 expression and DNA hydroxymethylation are affected by physical exercise in aged mice. Front Cell Dev Biol 6:45

pubmed: 29732371 pmcid: 5922180 doi: 10.3389/fcell.2018.00045

Hahn MA, Qiu R, Wu X, Li AX, Zhang H, Wang J et al (2013) Dynamics of 5-hydroxymethylcytosine and chromatin marks in Mammalian neurogenesis. Cell Rep 3(2):291–300

pubmed: 23403289 pmcid: 3582786 doi: 10.1016/j.celrep.2013.01.011

Zhang RR, Cui QY, Murai K, Lim YC, Smith ZD, Jin S et al (2013) Tet1 regulates adult hippocampal neurogenesis and cognition. Cell Stem Cell 13(2):237–45

pubmed: 23770080 pmcid: 4474382 doi: 10.1016/j.stem.2013.05.006

Laukka T, Mariani CJ, Ihantola T, Cao JZ, Hokkanen J, Kaelin WG Jr et al (2016) Fumarate and succinate regulate expression of hypoxia-inducible genes via TET enzymes. J Biol Chem 291(8):4256–65

pubmed: 26703470 doi: 10.1074/jbc.M115.688762

Zhang W, Xia W, Wang Q, Towers AJ, Chen J, Gao R et al (2016) Isoform switch of TET1 regulates DNA demethylation and mouse development. Mol Cell 64(6):1062–73

pubmed: 27916660 doi: 10.1016/j.molcel.2016.10.030

Good CR, Madzo J, Patel B, Maegawa S, Engel N, Jelinek J et al (2017) A novel isoform of TET1 that lacks a CXXC domain is overexpressed in cancer. Nucleic Acids Res 45(14):8269–81

pubmed: 28531272 pmcid: 5737541 doi: 10.1093/nar/gkx435

Dawlaty MM, Ganz K, Powell BE, Hu YC, Markoulaki S, Cheng AW et al (2011) Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. Cell Stem Cell 9(2):166–75

pubmed: 21816367 pmcid: 3154739 doi: 10.1016/j.stem.2011.07.010

Kim H, Jang WY, Kang MC, Jeong J, Choi M, Sung Y et al (2016) TET1 contributes to neurogenesis onset time during fetal brain development in mice. Biochem Biophys Res Commun 471(4):437–43

pubmed: 26902115 doi: 10.1016/j.bbrc.2016.02.060

Kwon W, Kim HS, Jeong J, Sung Y, Choi M, Park S et al (2018) Tet1 overexpression leads to anxiety-like behavior and enhanced fear memories via the activation of calcium-dependent cascade through Egr1 expression in mice. FASEB J 32(1):390–403

pubmed: 28899881 doi: 10.1096/fj.201601340RR

Greer CB, Wright J, Weiss JD, Lazarenko RM, Moran SP, Zhu J et al (2021) Tet1 isoforms differentially regulate gene expression, synaptic transmission, and memory in the mammalian brain. J Neurosci 41(4):578–93

pubmed: 33262245 pmcid: 7842754 doi: 10.1523/JNEUROSCI.1821-20.2020

Zhang M, Wang J, Zhang K, Lu G, Liu Y, Ren K et al (2021) Ten-eleven translocation 1 mediated-DNA hydroxymethylation is required for myelination and remyelination in the mouse brain. Nat Commun 12(1):5091

pubmed: 34429415 pmcid: 8385008 doi: 10.1038/s41467-021-25353-5

Shi G, Feng J, Jian LY, Fan XY (2023) DNA hypomethylation promotes learning and memory recovery in a rat model of cerebral ischemia/reperfusion injury. Neural Regen Res 18(4):863–8

pubmed: 36204855 doi: 10.4103/1673-5374.353494

Huang Y, Tian C, Li Q, Xu Q (2019) TET1 knockdown inhibits Porphyromonas gingivalis LPS/IFN-gamma-induced M1 macrophage polarization through the NF-kappaB pathway in THP-1 cells. Int J Mol Sci 20(8):2023

Yee KM SR, Liu B, Huynh CA, Niu C, Lee HR et al (2021) TET1 controls Cxcl1 induction by DNA demethylation and promotes neutrophil recruitment during acute lung injury. bioRxiv- Immunology 2021:9

Zhou D, Huang Z, Zhu X, Hong T, Zhao Y (2021) Circular RNA 0025984 ameliorates ischemic stroke injury and protects astrocytes through miR-143-3p/TET1/ORP150 pathway. Mol Neurobiol 58(11):5937–53

pubmed: 34435328 doi: 10.1007/s12035-021-02486-8

Mi Y, Gao X, Dai J, Ma Y, Xu L, Jin W (2015) A novel function of TET2 in CNS: sustaining neuronal survival. Int J Mol Sci 16(9):21846–57

pubmed: 26378518 pmcid: 4613284 doi: 10.3390/ijms160921846

Hahn MA, Jin SG, Li AX, Liu J, Huang Z, Wu X et al (2019) Reprogramming of DNA methylation at NEUROD2-bound sequences during cortical neuron differentiation. Sci Adv 5(10):eaax0080

pubmed: 31681843 pmcid: 6810389 doi: 10.1126/sciadv.aax0080

Gontier G, Iyer M, Shea JM, Bieri G, Wheatley EG, Ramalho-Santos M et al (2018) Tet2 rescues age-related regenerative decline and enhances cognitive function in the adult mouse brain. Cell Rep 22(8):1974–81

pubmed: 29466726 pmcid: 5870899 doi: 10.1016/j.celrep.2018.02.001

Fuster JJ, MacLauchlan S, Zuriaga MA, Polackal MN, Ostriker AC, Chakraborty R et al (2017) Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 355(6327):842–7

pubmed: 28104796 pmcid: 5542057 doi: 10.1126/science.aag1381

Qiu X, Dai Y, Cheng S, Gu HQ, Jiang Y, Meng X et al (2022) Somatic mutation contributing to clonal haematopoiesis is a risk factor of recurrent stroke in first-ever acute ischaemic stroke: a prospective cohort study. Stroke Vasc Neurol 8(2):103–10

pubmed: 36137598 pmcid: 10176982 doi: 10.1136/svn-2022-001756

Knudsen TA, Skov V, Stevenson K, Werner L, Duke W, Laurore C et al (2022) Genomic profiling of a randomized trial of interferon-alpha vs hydroxyurea in MPN reveals mutation-specific responses. Blood Adv 6(7):2107–19

pubmed: 34507355 pmcid: 9006286 doi: 10.1182/bloodadvances.2021004856

Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG et al (2014) Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med 371(26):2488–98

pubmed: 25426837 pmcid: 4306669 doi: 10.1056/NEJMoa1408617

Bhattacharya R, Zekavat SM, Haessler J, Fornage M, Raffield L, Uddin MM et al (2022) Clonal hematopoiesis is associated with higher risk of stroke. Stroke 53(3):788–97

pubmed: 34743536 doi: 10.1161/STROKEAHA.121.037388

Ji F, Zhao C, Wang B, Tang Y, Miao Z, Wang Y (2018) The role of 5-hydroxymethylcytosine in mitochondria after ischemic stroke. J Neurosci Res 96(10):1717–26

pubmed: 30043506 doi: 10.1002/jnr.24274

Ma Q, Dasgupta C, Shen G, Li Y, Zhang L (2021) MicroRNA-210 downregulates TET2 and contributes to inflammatory response in neonatal hypoxic-ischemic brain injury. J Neuroinflammation 18(1):6

pubmed: 33402183 pmcid: 7786974 doi: 10.1186/s12974-020-02068-w

Ma X, Zhang M, Yan R, Wu H, Yang B, Miao Z (2021) beta2SP/TET2 complex regulates gene 5hmC modification after cerebral ischemia. J Cell Mol Med 25(24):11300–9

pubmed: 34799994 pmcid: 8650033 doi: 10.1111/jcmm.17060

Yin M, Chen WP, Yin XP, Tu JL, Hu N, Li ZY (2021) LncRNA TUG1 demethylated by TET2 promotes NLRP3 expression, contributes to cerebral ischemia/reperfusion inflammatory injury. ASN Neuro 13:17590914211003248

pubmed: 33853366 pmcid: 8058810 doi: 10.1177/17590914211003247

Li Y, Song R, Shen G, Huang L, Xiao D, Ma Q et al (2023) MicroRNA-210 downregulates TET2 (ten-eleven translocation methylcytosine dioxygenase 2) and contributes to neuroinflammation in ischemic stroke of adult mice. Stroke 54(3):857–67

pubmed: 36734233 doi: 10.1161/STROKEAHA.122.041651

Miao Z, He Y, Xin N, Sun M, Chen L, Lin L et al (2015) Altering 5-hydroxymethylcytosine modification impacts ischemic brain injury. Hum Mol Genet 24(20):5855–66

pubmed: 26231219 pmcid: 4581609 doi: 10.1093/hmg/ddv307

Carrillo-Jimenez A, Deniz O, Niklison-Chirou MV, Ruiz R, Bezerra-Salomao K, Stratoulias V et al (2019) TET2 regulates the neuroinflammatory response in microglia. Cell Rep 29(3):697–713 e8

Cull AH, Snetsinger B, Buckstein R, Wells RA, Rauh MJ (2017) Tet2 restrains inflammatory gene expression in macrophages. Exp Hematol 55:56-70 e13

Wang L, Mao B, Fan K, Sun R, Zhang J, Liang H et al (2022) ROS attenuates TET2-dependent ZO-1 epigenetic expression in cerebral vascular endothelial cells. Fluids Barriers CNS 19(1):73

pubmed: 36076297 pmcid: 9461112 doi: 10.1186/s12987-022-00370-8

Antunes C, Da Silva JD, Guerra-Gomes S, Alves ND, Ferreira F, Loureiro-Campos E et al (2021) Tet3 ablation in adult brain neurons increases anxiety-like behavior and regulates cognitive function in mice. Mol Psychiatry 26(5):1445–57

pubmed: 32103150 doi: 10.1038/s41380-020-0695-7

Santiago M, Antunes C, Guedes M, Iacovino M, Kyba M, Reik W et al (2020) Tet3 regulates cellular identity and DNA methylation in neural progenitor cells. Cell Mol Life Sci 77(14):2871–83

pubmed: 31646359 doi: 10.1007/s00018-019-03335-7

Li T, Yang D, Li J, Tang Y, Yang J, Le W (2015) Critical role of Tet3 in neural progenitor cell maintenance and terminal differentiation. Mol Neurobiol 51(1):142–54

pubmed: 24838624 doi: 10.1007/s12035-014-8734-5

Lv X, Jiang H, Liu Y, Lei X, Jiao J (2014) MicroRNA-15b promotes neurogenesis and inhibits neural progenitor proliferation by directly repressing TET3 during early neocortical development. EMBO Rep 15(12):1305–14

pubmed: 25344561 pmcid: 4264933 doi: 10.15252/embr.201438923

Li X, Wei W, Zhao QY, Widagdo J, Baker-Andresen D, Flavell CR et al (2014) Neocortical Tet3-mediated accumulation of 5-hydroxymethylcytosine promotes rapid behavioral adaptation. Proc Natl Acad Sci U S A 111(19):7120–5

pubmed: 24757058 pmcid: 4024925 doi: 10.1073/pnas.1318906111

Antunes C, Da Silva JD, Guerra-Gomes S, Alves ND, Loureiro-Campos E, Pinto L et al (2022) Tet3 deletion in adult brain neurons of female mice results in anxiety-like behavior and cognitive impairments. Mol Neurobiol 59(8):4892–901

pubmed: 35665901 doi: 10.1007/s12035-022-02883-7

Morris-Blanco KC, Chokkalla AK, Bertogliat MJ, Vemuganti R (2021) TET3 regulates DNA hydroxymethylation of neuroprotective genes following focal ischemia. J Cereb Blood Flow Metab 41(3):590–603

pubmed: 32380888 doi: 10.1177/0271678X20912965

Morris-Blanco KC, Kim T, Lopez MS, Bertogliat MJ, Chelluboina B, Vemuganti R (2019) Induction of DNA hydroxymethylation protects the brain after stroke. Stroke 50(9):2513–21

pubmed: 31327315 pmcid: 6710106 doi: 10.1161/STROKEAHA.119.025665

Morris-Blanco KC, Chokkalla AK, Kim T, Bhatula S, Bertogliat MJ, Gaillard AB et al (2022) High-dose vitamin C prevents secondary brain damage after stroke via epigenetic reprogramming of neuroprotective genes. Transl Stroke Res 13(6):1017–36

pubmed: 35306630 pmcid: 9485293 doi: 10.1007/s12975-022-01007-6

Shi Q, Liu R, Chen L (2022) Ferroptosis inhibitor ferrostatin‑1 alleviates homocysteine‑induced ovarian granulosa cell injury by regulating TET activity and DNA methylation. Mol Med Rep 25(4):130

Liu X, Du Y, Liu J, Cheng L, He W, Zhang W (2023) Ferrostatin-1 alleviates cerebral ischemia/reperfusion injury through activation of the AKT/GSK3beta signaling pathway. Brain Res Bull 193:146–57

pubmed: 36596364 doi: 10.1016/j.brainresbull.2022.12.009

Zhang J, Zhang S, Wang Y, Cheng H, Hao L, Zhai Y et al (2017) Effect of TET inhibitor on bovine parthenogenetic embryo development. PLoS ONE 12(12):e0189542

pubmed: 29267337 pmcid: 5739418 doi: 10.1371/journal.pone.0189542

Shao L, Chen B, Wu Q, Xu Y, Yi J, Guo Z et al (2022) N(6)-methyladenosine-modified lncRNA and mRNA modification profiles in cerebral ischemia-reperfusion injury. Front Genet 13:973979

pubmed: 36479246 pmcid: 9720305 doi: 10.3389/fgene.2022.973979

Li Y, Li H, Luo Y, Li X, Chen Z, Zhang W et al (2022) The alteration profiles of m(6)A-tagged circRNAs in the peri-infarct cortex after cerebral ischemia in mice. Front Neurosci 16:869081

pubmed: 35747214 pmcid: 9209773 doi: 10.3389/fnins.2022.869081

Kim W, Kang MS, Kim TH, Yoo DY, Park JH, Jung HY et al (2020) Ischemia-related changes of fat-mass and obesity-associated protein expression in the gerbil hippocampus. Metab Brain Dis 35(2):335–42

pubmed: 31786728 doi: 10.1007/s11011-019-00513-1

Tao H, Dong L, Li L (2022) N6-methyladenosine modulation classes and immune microenvironment regulation in ischemic stroke. Front Mol Neurosci 15:1013076

pubmed: 36762188 pmcid: 9907088 doi: 10.3389/fnmol.2022.1013076

Zhong QQ, Zhu F (2022) Genetic loci, rs17817449 and rs6567160, known for obesity and the risk of stroke events among middle-aged and older Chinese people. Front Neurol 13:1036750

pubmed: 36530622 pmcid: 9755202 doi: 10.3389/fneur.2022.1036750

Stillman CM, Jakicic JM, Rogers RJ, Roecklein KA, Barrett G, Kang C et al (2022) The relationship between fat mass and obesity associated gene polymorphism rs9939609 and resting cerebral blood flow in a midlife sample with overweight and obesity. Front Hum Neurosci 16:904545

pubmed: 36072887 pmcid: 9443082 doi: 10.3389/fnhum.2022.904545

Olszewski PK, Radomska KJ, Ghimire K, Klockars A, Ingman C, Olszewska AM et al (2011) Fto immunoreactivity is widespread in the rodent brain and abundant in feeding-related sites, but the number of Fto-positive cells is not affected by changes in energy balance. Physiol Behav 103(2):248–53

pubmed: 21295049 doi: 10.1016/j.physbeh.2011.01.022

Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS et al (2007) The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318(5855):1469–72

pubmed: 17991826 pmcid: 2668859 doi: 10.1126/science.1151710

Du T, Li G, Yang J, Ma K (2020) RNA demethylase Alkbh5 is widely expressed in neurons and decreased during brain development. Brain Res Bull 163:150–9

pubmed: 32717204 doi: 10.1016/j.brainresbull.2020.07.018

Chokkalla AK, Jeong S, Mehta SL, Davis CK, Morris-Blanco KC, Bathula S et al (2023) Cerebroprotective role of N(6)-methyladenosine demethylase FTO (fat mass and obesity-associated protein) after experimental stroke. Stroke 54(1):245–54

pubmed: 36321453 doi: 10.1161/STROKEAHA.122.040401

Hou L, Li S, Li S, Wang R, Zhao M, Liu X (2023) FTO inhibits oxidative stress by mediating m6A demethylation of Nrf2 to alleviate cerebral ischemia/reperfusion injury. J Physiol Biochem 79(1):133–46

pubmed: 36327034 doi: 10.1007/s13105-022-00929-x

Wang QS, Xiao RJ, Peng J, Yu ZT, Fu JQ, Xia Y (2023) Bone marrow mesenchymal stem cell-derived exosomal KLF4 alleviated ischemic stroke through inhibiting N6-methyladenosine modification level of Drp1 by targeting lncRNA-ZFAS1. Mol Neurobiol 60(7):3945–3962

pubmed: 37002530 doi: 10.1007/s12035-023-03301-2

Li B, Xi W, Bai Y, Liu X, Zhang Y, Li L et al (2023) FTO-dependent m(6)A modification of Plpp3 in circSCMH1-regulated vascular repair and functional recovery following stroke. Nat Commun 14(1):489

pubmed: 36717587 pmcid: 9886939 doi: 10.1038/s41467-023-36008-y

Fu G, Du S, Huang T, Cao M, Feng X, Wu S et al (2021) FTO (fat-mass and obesity-associated protein) participates in hemorrhage-induced thalamic pain by stabilizing toll-like receptor 4 expression in thalamic neurons. Stroke 52(7):2393–403

pubmed: 34102854 pmcid: 8423095 doi: 10.1161/STROKEAHA.121.034173

Chen X, Yu C, Guo M, Zheng X, Ali S, Huang H et al (2019) Down-regulation of m6A mRNA methylation is involved in dopaminergic neuronal death. ACS Chem Neurosci 10(5):2355–63

pubmed: 30835997 doi: 10.1021/acschemneuro.8b00657

Selberg S, Yu LY, Bondarenko O, Kankuri E, Seli N, Kovaleva V et al (2021) Small-molecule inhibitors of the RNA M6A demethylases FTO potently support the survival of dopamine neurons. Int J Mol Sci 22(9):4537

Cockova Z, Honc O, Telensky P, Olsen MJ, Novotny J (2021) Streptozotocin-induced astrocyte mitochondrial dysfunction is ameliorated by FTO inhibitor MO-I-500. ACS Chem Neurosci 12(20):3818–28

pubmed: 34491720 doi: 10.1021/acschemneuro.1c00063

Ma C, Chang M, Lv H, Zhang ZW, Zhang W, He X et al (2018) RNA m(6)A methylation participates in regulation of postnatal development of the mouse cerebellum. Genome Biol 19(1):68

pubmed: 29855379 pmcid: 5984455 doi: 10.1186/s13059-018-1435-z

Xu K, Mo Y, Li D, Yu Q, Wang L, Lin F et al (2020) N(6)-methyladenosine demethylases Alkbh5/Fto regulate cerebral ischemia-reperfusion injury. Ther Adv Chronic Dis 11:2040622320916024

pubmed: 32426101 pmcid: 7222229 doi: 10.1177/2040622320916024

Du K, Zhang Z, Zeng Z, Tang J, Lee T, Sun T (2021) Distinct roles of Fto and Mettl3 in controlling development of the cerebral cortex through transcriptional and translational regulations. Cell Death Dis 12(7):700

pubmed: 34262022 pmcid: 8280107 doi: 10.1038/s41419-021-03992-2

Li L, Zang L, Zhang F, Chen J, Shen H, Shu L et al (2017) Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis. Hum Mol Genet 26(13):2398–411

pubmed: 28398475 pmcid: 6192412 doi: 10.1093/hmg/ddx128

Yang Y, Feng Y, Hu Y, Liu J, Shi H, Zhao R (2021) Exposure to constant light impairs cognition with FTO inhibition and m(6)A-dependent TrkappaB repression in mouse hippocampus. Environ Pollut 283:117037

pubmed: 33866220 doi: 10.1016/j.envpol.2021.117037

Bressler J, Fornage M, Demerath EW, Knopman DS, Monda KL, North KE et al (2013) Fat mass and obesity gene and cognitive decline: the atherosclerosis risk in communities study. Neurology 80(1):92–9

pubmed: 23136261 pmcid: 3589198 doi: 10.1212/WNL.0b013e3182768910

Ndubuizu OI, Chavez JC, LaManna JC (2009) Increased prolyl 4-hydroxylase expression and differential regulation of hypoxia-inducible factors in the aged rat brain. Am J Physiol Regul Integr Comp Physiol 297(1):R158-65

pubmed: 19420289 pmcid: 2711700 doi: 10.1152/ajpregu.90829.2008

Rebouche CJ, Engel AG (1980) Significance of renal gamma-butyrobetaine hydroxylase for carnitine biosynthesis in man. J Biol Chem 255(18):8700–5

pubmed: 6773946 doi: 10.1016/S0021-9258(18)43556-9

Zhang R, Zhang H, Zhang Z, Wang T, Niu J, Cui D et al (2012) Neuroprotective effects of pre-treatment with l-carnitine and acetyl-L-carnitine on ischemic injury in vivo and in vitro. Int J Mol Sci 13(2):2078–90

pubmed: 22408439 pmcid: 3292008 doi: 10.3390/ijms13022078

Recent Advances and Therapeutic Implications of 2-Oxoglutarate-Dependent Dioxygenases in Ischemic Stroke.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Subventions

Informations de copyright

Références

Auteurs

Jian Xie (J)

Zhijun Zhang (Z)

Classifications MeSH